Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases
Discovering bioactive compounds and their molecular mechanisms of disease resistance from natural organisms is an important frontier in current drug development, agricultural biological control, and life science research. This research not only provides new solutions for the treatment of human disea...
Сохранить в:
| Формат: | Online |
|---|---|
| Язык: | английский |
| Опубликовано: |
MDPI - Multidisciplinary Digital Publishing Institute
2026
|
| Предметы: | |
| Online-ссылка: | https://directory.doabooks.org/handle/20.500.12854/170636 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
| _version_ | 1869520979698384896 |
|---|---|
| collection | Directory of Open Access Books |
| description | Discovering bioactive compounds and their molecular mechanisms of disease resistance from natural organisms is an important frontier in current drug development, agricultural biological control, and life science research. This research not only provides new solutions for the treatment of human diseases and the prevention and control of animal and plant diseases and pests, but it also provides key clues for understanding the molecular mechanisms of life activities. However, the research and development of synthetic drugs is currently facing increasingly severe challenges, which are manifested in rising research and development costs, longer cycles, a sharp decline in success rates, and increasingly serious environmental pollution problems. Therefore, finding lead compounds to develop new drugs has become a core priority for major pharmaceutical companies. During the long evolutionary process, organisms have synthesized a large number of secondary metabolites with novel and unique structures. The differences in the chemical properties of these organisms not only give them diverse biological activities but also provide the possibility of exploring new mechanisms of action. Therefore, they have become an indispensable resource in the development of new drugs—people are working to discover new lead compounds from millions of plants, animals, microorganisms, and marine organisms in nature. This reprint is highly recommended for researchers, students, and industry professionals because it provides new insights into “bioactive compounds and their molecular mechanisms of disease resistance”. |
| format | Online |
| id | doab-20.500.12854ir-170636 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1706362026-01-02T16:19:27Z Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases Dang, Jun Ji, Tengfei Zhang, Xinxin Drug synthetic drug new drug lead compound secondary metabolite Discovering bioactive compounds and their molecular mechanisms of disease resistance from natural organisms is an important frontier in current drug development, agricultural biological control, and life science research. This research not only provides new solutions for the treatment of human diseases and the prevention and control of animal and plant diseases and pests, but it also provides key clues for understanding the molecular mechanisms of life activities. However, the research and development of synthetic drugs is currently facing increasingly severe challenges, which are manifested in rising research and development costs, longer cycles, a sharp decline in success rates, and increasingly serious environmental pollution problems. Therefore, finding lead compounds to develop new drugs has become a core priority for major pharmaceutical companies. During the long evolutionary process, organisms have synthesized a large number of secondary metabolites with novel and unique structures. The differences in the chemical properties of these organisms not only give them diverse biological activities but also provide the possibility of exploring new mechanisms of action. Therefore, they have become an indispensable resource in the development of new drugs—people are working to discover new lead compounds from millions of plants, animals, microorganisms, and marine organisms in nature. This reprint is highly recommended for researchers, students, and industry professionals because it provides new insights into “bioactive compounds and their molecular mechanisms of disease resistance”. 2026-01-02T16:19:24Z 2026-01-02T16:19:24Z 2025 book 978-3-7258-4899-7 https://directory.doabooks.org/handle/20.500.12854/170636 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books https://mdpi.com/books/pdfview/topic/11364 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-4900-0 10.3390/books978-3-7258-4900-0 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 978-3-7258-4899-7 498 CH open access |
| spellingShingle | Drug synthetic drug new drug lead compound secondary metabolite Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases |
| title | Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases |
| title_full | Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases |
| title_fullStr | Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases |
| title_full_unstemmed | Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases |
| title_short | Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases |
| title_sort | discovery of bioactive compounds from natural organisms and their molecular mechanisms against diseases |
| topic | Drug synthetic drug new drug lead compound secondary metabolite |
| topic_facet | Drug synthetic drug new drug lead compound secondary metabolite |
| url | https://directory.doabooks.org/handle/20.500.12854/170636 |